| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.077 | 0.2 |